Birgitte Giersing PhD, APMP

Birgitte Giersing leads the Vaccine Prioritisation and Platform work within the Product and Delivery Research Unit, in WHO’s Immunization Department. She is the secretariat for the Product Development for Vaccines Advisory Committee (PDVAC), working across a number of pathogens areas and vaccine platforms, and is the WHO focal point for the Vaccine Innovation Prioritisation Strategy (VIPS). She has approximately 20 years of vaccine product development experience, having led vaccine development programs in the private and non-profit sector before joining WHO 6 years ago. She trained as a biochemist and performed her post-doctoral studies at the National Institutes of Health, the USA in malaria vaccine development.